ACHELOIS BIOPHARMA
Achelois develops programmable therapeutics for cancer, viral infections, autoimmune, and inflammatory diseases.
ACHELOIS BIOPHARMA
Industry:
Biopharma Biotechnology Test And Measurement
Founded:
2013-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.achelois.bio
Total Employee:
11+
Status:
Active
Contact:
+1 650 562 7861
Email Addresses:
[email protected]
Similar Organizations
Ampersand Biomedicines
Ampersand Biomedicines develops novel programming therapeutics that are designed to act at the sight of disease.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Groove Biopharma
Groove Biopharma develops novel microRNA therapeutics for maladies including cancer, fibrosis and infectious diseases.
Official Site Inspections
http://www.achelois.bio
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Achelois BioPharma"
Immunotherapy for Cancer and Viruses - Achelois …
Achelois BioPharma develops curative, programmable Multivalent Therapeutics to treat cancer, viral infection, autoimmune, and inflammatory diseases. Unlike …See details»
Achelois BioPharma - Crunchbase Company Profile & Funding
Achelois develops curative, programmable Multivalent Therapeutics to treat cancer, viral infections, autoimmune, and inflammatory diseases. The company focuses on genetic …See details»
Achelois BioPharma, Inc. | LinkedIn
Achelois BioPharma, Inc. | 160 followers on LinkedIn. Programmable Multivalent Therapeutics | Achelois BioPharma develops programmable, Multivalent …See details»
Achelois Biopharma, Inc. - Drug pipelines, Patents, …
May 8, 2025 Explore Achelois Biopharma, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology …See details»
ACHELOIS BIOPHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACHELOIS BIOPHARMA, INC. of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Achelois - VentureRadar
Achelois is a biopharmaceutical company focused on the development of broad-spectrum and nontoxic cancer therapeutics. The company's mission is to develop effective and nontoxic …See details»
Achelois BioPharma - PitchBook
Achelois BioPharma was founded in 2013. Where is Achelois BioPharma headquartered? Achelois BioPharma is headquartered in Redwood City, CA. What industry is Achelois …See details»
Achelois BioPharma, Inc. Overview | SignalHire Company Profile
Organization Website: achelois.bio : Achelois BioPharma, ... industries Biotech: Headquarters Location: 3698 Haven Ave, Redwood City, California, 94063 US 3698 Haven Ave, Redwood …See details»
About Our Company - Achelois BioPharma
Achelois BioPharma. 3698 Haven Ave., Ste. A. Redwood City, CA 94063. [email protected]. Page load link. ... He recently served as Chief Science …See details»
Achelois BioPharma - Nature
Www.achelois.bio Enabling T cell therapy for established solid ... and Achelois’ manufacturing facility and processes. A few anti-tumor T cells (blue) among billions other T cells (yellow)See details»
Achelois BioPharma - Products, Competitors, Financials, Employees ...
Headquarters Location. 3698 Haven Avenue Suite A. Redwood City, California, 94063, United States. 650-279-7468See details»
Achelois BioPharma, Inc. - VentureRadar
Doma Bio China n/a Doma is an innovative biotechnology company with an independent drug research and development pipeline that also functions as a biotech incubator with flexible and …See details»
Chang-Zheng Chen - CEO & Founder @ Achelois BioPharma
Chang-Zheng Chen is the Foundera nd CEO of Achelois BioPharma. He previously worked at Stanford University School of Medicine as a Faculty M... New. Resources. Advanced Search. …See details»
Achelois BioPharma, Inc. on LinkedIn: At Achelois, we discovered ...
At Achelois, we discovered genetic-enhancing modifiers (GEMs) that can reprogram tumor-targeting T cells to overcome immune suppression and eliminate cancer. GEMs can be used …See details»
Achelois BioPharma, Inc. - Drug pipelines, Patents, Clinical trials ...
Aug 5, 2024 Last update 20 Jul 2024. Achelois BioPharma, Inc. Company |See details»
Virus & Cancer Treatment Programs - Achelois BioPharma
Achelois has developed variant-resistant antiviral therapeutics, called Antiviruses, to fight and prevent COVID-19. Using multivalent display technology inspired by viruses themselves, …See details»
achelois.bio Reviews: Is this site a scam or legit?
Is achelois.bio legit or a scam? Read reviews, company details, technical analysis, and more to help you decide if this site is trustworthy or fraudulent.See details»
Enabling T cell therapy for established solid tumors using genetic ...
Achelois BioPharma has built a screening platform to discover T cell-intrinsic genetic-enhancing modifiers that enable tumor-specific T cells to eliminate established tumors in preclinical …See details»
Achelois BioPharma, Inc.’s Post - LinkedIn
Meet Dr. Chen, the founder & CEO of Achelois BioPharma. Before starting Achelois, Dr. Chen was on the faculty at Stanford University School of Medicine. He made pioneering …See details»
BIO 2025: Breakthroughs can't wait. | BIO - bio.org
1 day ago America’s leadership in biotech is essential to national security—and it’s under threat, said the National Security Commission on Emerging Biotechnology (NSCEB) in a BIO 2025 …See details»